KROS
Keros Therapeutics Inc.
$17.39
+$0.57(+3.39%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$500.56M
Volume
1.44M
52W Range
$9.12 - $72.37
Target Price
$23.25
EPS Estimates Overview
| Current Quarter | $-0.53 | Next Quarter | $-0.55 |
| Current Year | $1.92 | Next Year | $-3.65 |
| QoQ Growth | -3.8% | YoY Growth | -290.1% |
| 3Y EPS CAGR | -25.7% | Target Price | $23.25 |
| Consensus | Buy | Upside | +33.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $17.39 | +3.4% | 1.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |